-0.19 | -2.17%
| Price and Volume | |
|---|---|
| Recent Price | 8.74 |
| 52 Week High | 11.79 |
| 52 Week Low | 4.48 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | -0.03 |
| Share Related Items | |
| Mkt Cap (Mil) | 318.49 |
| Shares Out (Mil) | 36.44 |
| Float (Mil) | 29.34 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.00 |
| Current Ratio | 3.10 |
| LT Debt/ Equity | 0.02 |
| Total Debt / Equity | 0.13 |
| Valuation Ratios | |
| Price Earnings | 218.50 |
| Price/Sales | 5.02 |
| Price/Book | 10.37 |
| Price/Cash Flow | 90.10 |
| Per Share Data | |
| Earnings | 0.04 |
| Sales | 1.74 |
| Book Value | 0.84 |
| Cash Flow | 0.10 |
| Business Summary | |
|---|---|
| STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye. It is a maker of lenses used worldwide in corrective or refractive surgery, and it also make lenses for use in surgery that treats cataracts. | |
| General Information | |
| 1911 Walker Avenue
Monrovia, CA 91016 |
|
| www.staar.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 297 | |
| CEO: Barry G. Caldwell | |
| Short Interest | |
| Current Month (Mil) | 2.66 |
| Previous Month (Mil) | 2.46 |
| Short Interest Ratio (Days) | 17.40 |
| Management Effectiveness | |
| Return on Equity | 4.20 |
| Return on Assets | 2.60 |
| Return on Investments | 4.10 |
| Profitability | |
| Gross Margin | 72.40 |
| EBIT Margin | 4.80 |
| Profit Margin | 2.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet